Intracranial Vascular Procedures with Hemorrhage DRG

DRG 020 groups admissions for intracranial vascular procedures with a principal diagnosis of intracranial hemorrhage accompanied by a Major Complication or Comorbidity, reflecting high-acuity neurosurgical care. This classification matters for inpatient reimbursement because the Major Complication or Comorbidity designation increases expected resource use and payment under Medicare Severity Diagnosis-Related Group methodology.

DRG 020 Overview

DRG 020 covers inpatient stays for intracranial vascular procedures performed when the principal diagnosis is intracranial hemorrhage with Major Complication or Comorbidity. These cases typically include surgical or endovascular interventions for ruptured cerebral aneurysms, arteriovenous malformations, or other hemorrhagic vascular lesions complicated by significant physiological derangement. This Diagnosis-Related Group is important for Medicare payment because the presence of a Major Complication or Comorbidity increases resource intensity and therefore influences reimbursement levels under Medicare Severity Diagnosis-Related Group payment rules.

Acute endovascular intervention trials: randomized or prospective registry studies evaluating timing, techniques, and periprocedural management of endovascular procedures (e.g., coiling, flow diversion, or embolization adjuncts) performed for intracranial hemorrhage due to ruptured cerebral aneurysms or vascular malformations. These studies focus on the immediate inpatient period, enrolling adults who present with subarachnoid or intracerebral hemorrhage requiring urgent intracranial vascular procedures, and assess procedural success, rebleeding rates, and early neurologic outcomes. Results inform surgical and interventional practice patterns and are directly relevant to providers and payers because they influence resource utilization, length of stay, and complication-driven costs in this high-acuity DRG.
Comparative effectiveness and perioperative care studies: nonrandomized cohort studies or pragmatic trials comparing different perioperative strategies such as blood pressure management protocols, transfusion thresholds, antithrombotic reversal approaches, or intensive care unit monitoring pathways in patients undergoing intracranial vascular procedures for hemorrhagic diagnoses. These research efforts enroll medically heterogeneous patients (varying comorbidity burden and hemorrhage severity) to determine which perioperative practices reduce complications like rebleeding, vasospasm, or procedure-related infarction, and to evaluate impacts on complication rates and hospital resource use. Findings are critical for clinicians and payers to standardize care pathways that lower morbidity and cost while optimizing discharge readiness for this DRG population.
Post-discharge outcomes and rehabilitation studies: longitudinal observational studies and randomized rehabilitation interventions assessing functional recovery, cognitive outcomes, readmission rates, and long-term care needs among survivors of intracranial hemorrhage who underwent vascular procedures and had major complications (MCC). These studies follow patients after hospital discharge to evaluate predictors of durable independence, the effectiveness of early supported discharge or specialized neurorehabilitation, and the economic impact of ongoing care needs. Such evidence guides discharge planning, bundling/payment strategies, and investment in outpatient or home-based services that affect total cost of care and payer outcomes for patients classified under this DRG.

Acute endovascular intervention trials: randomized or prospective registry studies evaluating timing, techniques, and periprocedural management of endovascular procedures (e.g., coiling, flow diversion, or embolization adjuncts) performed for intracranial hemorrhage due to ruptured cerebral aneurysms or vascular malformations. These studies focus on the immediate inpatient period, enrolling adults who present with subarachnoid or intracerebral hemorrhage requiring urgent intracranial vascular procedures, and assess procedural success, rebleeding rates, and early neurologic outcomes. Results inform surgical and interventional practice patterns and are directly relevant to providers and payers because they influence resource utilization, length of stay, and complication-driven costs in this high-acuity DRG.
Comparative effectiveness and perioperative care studies: nonrandomized cohort studies or pragmatic trials comparing different perioperative strategies such as blood pressure management protocols, transfusion thresholds, antithrombotic reversal approaches, or intensive care unit monitoring pathways in patients undergoing intracranial vascular procedures for hemorrhagic diagnoses. These research efforts enroll medically heterogeneous patients (varying comorbidity burden and hemorrhage severity) to determine which perioperative practices reduce complications like rebleeding, vasospasm, or procedure-related infarction, and to evaluate impacts on complication rates and hospital resource use. Findings are critical for clinicians and payers to standardize care pathways that lower morbidity and cost while optimizing discharge readiness for this DRG population.
Post-discharge outcomes and rehabilitation studies: longitudinal observational studies and randomized rehabilitation interventions assessing functional recovery, cognitive outcomes, readmission rates, and long-term care needs among survivors of intracranial hemorrhage who underwent vascular procedures and had major complications (MCC). These studies follow patients after hospital discharge to evaluate predictors of durable independence, the effectiveness of early supported discharge or specialized neurorehabilitation, and the economic impact of ongoing care needs. Such evidence guides discharge planning, bundling/payment strategies, and investment in outpatient or home-based services that affect total cost of care and payer outcomes for patients classified under this DRG.

OpenPayer

Summary & Overview

Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

DRG 020 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes